MYC and T-cell leukemia: MYC binds to HIF2α gene promoter preferentially in Sca1+ cancer stem cells (CSCs) in a MYC-driven mouse T-cell leukemia model and the equivalent ABCG2+ CSC population in human acute lymphoblastic lymphomas and activates HIF2α expression (Das et al., 2019).